EBNA leader protein orchestrates chromatin architecture remodeling during Epstein-Barr virus-induced B cell transformation
Nucleic Acids Research · 20.06.2025 · 53 (12)
DOI: 10.1093/nar/gkaf629 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 02.07.2025. Verfasst von Davide Maestri und 7 weiteren Autor:innen. Beteiligte Einrichtung: The Wistar Institute, Genome Regulation and Cell Signaling Program, 3601 Spruce Street Philadelphia PA 19104, United States. Hauptthemen laut MEDLINE: Herpesvirus 4, Human, B-Lymphocytes, Chromatin Assembly and Disassembly, Epstein-Barr Virus Nuclear Antigens. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, NIH HHS, Cancer Center Support Grant.
Abstract (Originalsprache)
Epstein-Barr virus Nuclear Antigen Leader Protein (EBNA-LP) plays a pivotal role in the transformation of B cells by Epstein-Barr virus (EBV), functioning independently of EBNA2 to regulate chromatin architecture and gene expression. Our study reveals that EBNA-LP binds to chromatin regions distinct from EBNA2 and facilitates the formation of long-distance chromatin loops by interacting with the cellular factor YY1. This interaction reconfigures the three-dimensional structure of the host genome, enhancing the integrity of topologically associating domains (TADs) and promoting the interaction between enhancers and promoters within these domains. In EBV-infected B cells, EBNA-LP strengthens YY1-mediated chromatin loops within TADs, which helps maintain stable regulatory programs essential for B cell transformation. Notably, EBNA-LP is crucial for establishing EBV-induced enhancers, yet it is not required for their maintenance once formed. Additionally, our data suggest a compensatory increase in CTCF binding in the absence of EBNA-LP, leading to more promiscuous chromatin interactions between TADs and a reduced TAD insulation at their boundaries. These findings provide new insights into the molecular mechanisms by which EBV reshapes the host genome chromatin architecture to support B cell transformation and highlight potential therapeutic targets for disrupting EBV-driven oncogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- The Wistar Institute, Genome Regulation and Cell Signaling Program, 3601 Spruce Street Philadelphia PA 19104, United States.
- Department of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC 27710, United States.
- Section of Virology, Department of Infectious Disease, Imperial College London, London, SW7 2AZ, United Kingdom.
ORCID-Profile: Italo Tempera
Förderung
- NCI NIH HHS
- NIH HHS
- Cancer Center Support Grant
- NIH
Zitieren
APA
Maestri, D., Caruso, L. B., Cable, J. M., Sklutuis, R., Preston-Alp, S., White, R. E., Luftig, M. A., & Tempera, I. (2025). EBNA leader protein orchestrates chromatin architecture remodeling during Epstein-Barr virus-induced B cell transformation. Nucleic Acids Research, 53(12). https://doi.org/10.1093/nar/gkaf629
Vancouver
Maestri D, Caruso LB, Cable JM, Sklutuis R, Preston-Alp S, White RE, et al. EBNA leader protein orchestrates chromatin architecture remodeling during Epstein-Barr virus-induced B cell transformation. Nucleic Acids Research. 2025;53(12). doi:10.1093/nar/gkaf629
BibTeX
@article{Maestri2025,
author = {Maestri, Davide and Caruso, Lisa B and Cable, Jana M and Sklutuis, Rachel and Preston-Alp, Sarah and White, Robert E and Luftig, Micah A and Tempera, Italo},
title = {EBNA leader protein orchestrates chromatin architecture remodeling during Epstein-Barr virus-induced B cell transformation},
journal = {Nucleic Acids Research},
year = {2025},
volume = {53},
number = {12},
doi = {10.1093/nar/gkaf629}
}
EUVIMED